Elderly patients with prior adenomas face low absolute cancer risk, raising questions about surveillance colonoscopy value
Current guidelines recommend surveillance colonoscopies for people who had polyps (adenomas) found on a prior colonoscopy. But for elderly patients, the benefits versus burdens of continued surveillance are less clear — especially as competing causes of death become more prominent with age.
Elderly patients with prior adenomas face low absolute cancer risk, raising questions about surveillance colonoscopy value
Current guidelines recommend surveillance colonoscopies for people who had polyps (adenomas) found on a prior colonoscopy. But for elderly patients, the benefits versus burdens of continued surveillance are less clear — especially as competing causes of death become more prominent with age.
This study found that older adults with prior adenoma were indeed more likely to develop colorectal cancer and die from it compared to those without adenomas. However, the absolute cumulative incidence was low and was dramatically outnumbered by non-cancer mortality in this age group. In other words, while the relative risk increase exists, most elderly people with prior adenomas won't die from colorectal cancer — they'll die from something else first.
These findings prompt a rethinking of how aggressively surveillance colonoscopy should be pursued in older patients, particularly those with comorbidities. The data support a more individualized, risk-stratified approach rather than blanket surveillance recommendations.
Key Findings
- Elderly patients with prior adenoma had higher rates of colorectal cancer diagnosis and death than adenoma-free peers
- However, absolute cumulative colorectal cancer incidence was low in this age group
- Non-cancer mortality far exceeded colorectal cancer mortality in elderly adenoma patients
- Findings challenge the value of routine surveillance colonoscopy in older adults
- Results support individualized, risk-benefit-based surveillance decisions in the elderly
Implications
Gastroenterologists and primary care physicians should reconsider automatic surveillance colonoscopy referrals in older patients with prior adenomas, particularly in those with significant comorbidities and limited life expectancy. A shared decision-making approach that weighs colonoscopy risks against modest absolute cancer risk benefit would be appropriate.
Caveats
News summary only; full study design, sample size, and follow-up duration not available. Observational study; patient populations may differ in ways that affect cancer risk. Age thresholds for reduced surveillance benefit need definition. Summary based on abstract only.
Source: MedPage Hematology/Oncology — 2026-04-09
